154 related articles for article (PubMed ID: 38056905)
1. Hybrid Membrane Camouflaged Chemodrug-Gene Nanoparticles for Enhanced Combination Therapy of Ovarian Cancer.
Chen T; Wang Y; Zhu L; Wu J; Lin J; Huang W; Yan D
ACS Appl Mater Interfaces; 2023 Dec; 15(50):58067-58078. PubMed ID: 38056905
[TBL] [Abstract][Full Text] [Related]
2. Cancer-cell-membrane-camouflaged supramolecular self-assembly of antisense oligonucleotide and chemodrug for targeted combination therapy.
Chen T; Xu J; Zhu L; Yan D
Nanoscale; 2023 Jan; 15(4):1914-1924. PubMed ID: 36617999
[TBL] [Abstract][Full Text] [Related]
3. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
4. A RBC membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of cervical cancer.
Luo L; Zeng F; Xie J; Fan J; Xiao S; Wang Z; Xie H; Liu B
J Mater Chem B; 2020 May; 8(18):4080-4092. PubMed ID: 32239064
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Erythrocyte Hybrid Membrane-Camouflaged Magnetic Nanoparticles with Enhanced Photothermal-Immunotherapy for Ovarian Cancer.
Xiong J; Wu M; Chen J; Liu Y; Chen Y; Fan G; Liu Y; Cheng J; Wang Z; Wang S; Liu Y; Zhang W
ACS Nano; 2021 Dec; 15(12):19756-19770. PubMed ID: 34860006
[TBL] [Abstract][Full Text] [Related]
7. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors.
Zhang M; Zhang F; Liu T; Shao P; Duan L; Yan J; Mu X; Jiang J
Int J Nanomedicine; 2020; 15():10183-10197. PubMed ID: 33363374
[TBL] [Abstract][Full Text] [Related]
8. RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer.
Liu B; Wang W; Fan J; Long Y; Xiao F; Daniyal M; Tong C; Xie Q; Jian Y; Li B; Ma X; Wang W
Biomaterials; 2019 Oct; 217():119301. PubMed ID: 31279101
[TBL] [Abstract][Full Text] [Related]
9. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
Bartholomeusz C; Itamochi H; Yuan LX; Esteva FJ; Wood CG; Terakawa N; Hung MC; Ueno NT
Cancer Res; 2005 Sep; 65(18):8406-13. PubMed ID: 16166319
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte membrane camouflaged siRNA/chemodrug nanoassemblies for cancer combination therapy.
Xu J; Chen T; Sun T; Yu C; Yan D; Zhu L
Biomater Sci; 2022 Nov; 10(22):6601-6613. PubMed ID: 36250610
[TBL] [Abstract][Full Text] [Related]
13. Stealth Polydopamine-Based Nanoparticles with Red Blood Cell Membrane for the Chemo-Photothermal Therapy of Cancer.
Wang H; Williams GR; Xie X; Wu M; Wu J; Zhu LM
ACS Appl Bio Mater; 2020 Apr; 3(4):2350-2359. PubMed ID: 35025285
[TBL] [Abstract][Full Text] [Related]
14. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy.
Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q
J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Gao L; Wang H; Nan L; Peng T; Sun L; Zhou J; Xiao Y; Wang J; Sun J; Lu W; Zhang L; Yan Z; Yu L; Wang Y
Bioconjug Chem; 2017 Oct; 28(10):2591-2598. PubMed ID: 28872851
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics.
Wang S; Wang Y; Jin K; Zhang B; Peng S; Nayak AK; Pang Z
Expert Opin Drug Deliv; 2022 Aug; 19(8):965-984. PubMed ID: 35917435
[TBL] [Abstract][Full Text] [Related]
18. Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion.
Wang X; Li H; Liu X; Tian Y; Guo H; Jiang T; Luo Z; Jin K; Kuai X; Liu Y; Pang Z; Yang W; Shen S
Biomaterials; 2017 Oct; 143():130-141. PubMed ID: 28800434
[TBL] [Abstract][Full Text] [Related]
19. Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells.
Bai DP; Zhang XF; Zhang GL; Huang YF; Gurunathan S
Int J Nanomedicine; 2017; 12():6521-6535. PubMed ID: 28919752
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of long circulating erythrocyte membrane-cloaked anti-cancer drug delivery system.
Chu Y; Zhang J; Pan H; Shi J; Wang J; Chen L
Drug Deliv Transl Res; 2020 Oct; 10(5):1278-1287. PubMed ID: 32399603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
